Synergistic mechanisms and clinical translation of regorafenib combination therapies.

Liang S, Zheng D, Chu T, Yang D, Zhang K, Yang L, Yang Y, Ma W.

Open source

DOI
10.1007/s12094-025-04202-7
Published
2026-01-13
Container
Clin Transl Oncol
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12094-025-04202-7,
  title = {Synergistic mechanisms and clinical translation of regorafenib combination therapies.},
  author = {Liang S and  Zheng D and  Chu T and  Yang D and  Zhang K and  Yang L and  Yang Y and  Ma W.},
  year = {2026},
  journal = {Clin Transl Oncol},
  doi = {10.1007/s12094-025-04202-7},
  url = {https://doi.org/10.1007/s12094-025-04202-7}
}

RIS

TY  - JOUR
TI  - Synergistic mechanisms and clinical translation of regorafenib combination therapies.
AU  - Liang S
AU  -  Zheng D
AU  -  Chu T
AU  -  Yang D
AU  -  Zhang K
AU  -  Yang L
AU  -  Yang Y
AU  -  Ma W.
PY  - 2026
JO  - Clin Transl Oncol
DO  - 10.1007/s12094-025-04202-7
UR  - https://doi.org/10.1007/s12094-025-04202-7
ER  - 

APA

S, L., D, Z., T, C., D, Y., K, Z., L, Y., Y, Y., & W., M. (2026). Synergistic mechanisms and clinical translation of regorafenib combination therapies.. Clin Transl Oncol. https://doi.org/10.1007/s12094-025-04202-7

Source records